Last reviewed · How we verify

NCT03197428

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Completed NA Last updated 4 April 2019
What this trial tests

NA trial testing Platelet-rich plasma in Ankle Instability in 20 participants. Completed in 31 January 2019.

Timeline
5 July 2016
Primary endpoint
12 January 2019
31 January 2019

Quick facts

Lead sponsorPei-Yuan Lee, MD
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date5 July 2016
Primary completion12 January 2019
Estimated completion31 January 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Pei-Yuan Lee, MD

Who can join

Adults 20 to 60, any sex, with Ankle Instability or Platelet-rich Plasma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effect of platelet-rich plasma (PRP) on chronic lateral ankle instability by comparing the imaging and clinical outcomes between patients receiving PRP and those receiving whole blood during the modified Broström-Gould procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet-rich plasma

Trials testing the same drug.

Other recruiting trials for Ankle Instability

Currently open trials in the same condition.

Other Pei-Yuan Lee, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03197428.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing